McKesson MCK

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$19.84 (+2.94%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

McKesson (MCK) Business Model and Operations Summary
McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Key Insights

McKesson (MCK) Core Market Data and Business Metrics
  • Latest Closing Price

    $693.53
  • Market Cap

    $85.64 Billion
  • Price-Earnings Ratio

    35.95
  • Total Outstanding Shares

    126.94 Million Shares
  • Total Employees

    51,000
  • Dividend

    $0.71 Per Share Quarterly
  • IPO Date

    August 3, 1987
  • SIC Description

    Wholesale-drugs, Proprietaries & Druggists' Sundries
  • Primary Exchange

    New York Stock Exchange
  • Headquarters

    6555 State Highway 161, Irving, TX, 75039

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Short Interest

Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
Avg Daily VolumeDays to CoverSettlement DateShort Interest
964,312 Shares2.163/14/20252,086,597 Shares
859,093 Shares2.152/28/20251,846,222 Shares
929,894 Shares2.012/14/20251,866,473 Shares
672,300 Shares2.211/31/20251,488,818 Shares
651,452 Shares2.451/15/20251,595,918 Shares
804,267 Shares1.9512/31/20241,569,663 Shares

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Operating Activities, Continuing$5.12 Billion
Net Cash Flow From Financing Activities$-4.00 Billion
Net Cash Flow$1 Million
Net Cash Flow From Investing Activities, Continuing$-1.13 Billion
Exchange Gains/Losses$8 Million
Net Cash Flow From Financing Activities, Continuing$-4.00 Billion

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Basic Earnings Per Share$19.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0
Net Income/Loss Attributable To Noncontrolling Interest$171 Million
Interest Expense, Operating$297 Million
Income/Loss From Continuing Operations Before Tax$3.40 Billion
Income/Loss From Continuing Operations After Tax$2.71 Billion

Comprehensive Income

October 1, 2023 to September 30, 2024
MetricValue
Comprehensive Income/Loss Attributable To Parent$2.53 Billion
Other Comprehensive Income/Loss$-3 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$171 Million
Other Comprehensive Income/Loss Attributable To Parent$-3 Million
Comprehensive Income/Loss$2.70 Billion

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Noncurrent Liabilities$16.30 Billion
Accounts Payable$53.32 Billion
Current Assets$53.34 Billion
Fixed Assets$2.36 Billion
Assets$72.43 Billion
Long-term Debt$5.74 Billion

Historical Dividends

Current dividend: $0.71 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Jan 30, 2025Apr 1, 2025Mar 3, 2025$0.71Quarterly
Oct 31, 2024Jan 2, 2025Dec 2, 2024$0.71Quarterly
Aug 1, 2024Oct 1, 2024Sep 2, 2024$0.71Quarterly
Apr 24, 2024Jul 1, 2024Jun 3, 2024$0.62Quarterly
Feb 1, 2024Apr 1, 2024Mar 1, 2024$0.62Quarterly
Oct 26, 2023Jan 2, 2024Dec 1, 2023$0.62Quarterly

Recent Headlines From The Web

Latest news, press releases, and media coverage about MCK from trusted financial sources

    Related Companies

    Publicly traded companies similar to McKesson (MCK)